Longenesis Expands Blockchain-Based Medical Consent Platform in South Korea
Bitfury-Backed Project Partners With Hanshin Medipia Medical Center And Infinity Care
Seoul, July 1, 2019
Today Longenesis announced it is expanding its blockchain-based medical consent platform to two major South Korean medical institutions — the Hanshin Medipia Medical Center and Infinity Care. Both centers are regional leaders in preventive medicine, specializing in early stage disease diagnosis and prevention.
Longenesis will integrate its blockchain platform to help both partners with data compliance for both foreign patients (requiring HIPAA and GDPR compliance) and local patients. The platform will also streamline patient onboarding and ongoing care through the use of an extended
blockchain toolkit. The platform is built on Bitfury’s Exonum™ enterprise-grade blockchain framework.
“We believe, through this partnership, that both Hanshin Medipia Medical Center and Infinity Care will be able to improve the quality and efficiency of their services, as well as increase the quality and quantity of data available for R&D and drug development,” said Garri Zmudze, CEO of Longenesis. “Our platform is designed for any medical institution interested in building a more
transparent and trusting relationship with their patients while also helping more medical data become available for crucial research.”
The toolkit built by Longenesis is comprised of a consent management tool, an easy-to-use B2C interface, a quality assessment module and patient dashboard.
- The consent management tool makes it easy to track and manage user consent for individual studies and medical trials, while also making it easy for users to change or withdraw their consent for these studies at any time.
- The B2C interface provides the organization with a method for faster direct
communication with the patient.
- The quality assessment tool will help Hanshin Medipia and Infinity Care better analyze and assess the treatment quality of their patients in real-time, helping them to evaluate the performance of doctors and safeguard patient care.
- Finally, the dashboard enables pharmaceutical companies and research organizations to search among anonymized metadata for the specific datasets they require for their research and clinical trials, and then effortlessly onboard the targeted patients.
For more information, visit www.longenesis.com.
Media Contact: Deniss Bazinovs email@example.com
About Hanshin Medipia Medical Center
Hanshin Medipia is a top General Surgery clinic located in Seoul, South Korea. In this clinic, with high-quality equipment and dedicated staff, you can find a solution for multiple medical problems that you may have, starting from some simple procedures to really complex ones: laparoscopic surgery, trauma surgery, vascular surgery, Colorectal surgery, breast surgery, transplant surgery, endocrine surgery, pediatric surgery, surgical oncology, cardiothoracic surgery. Hanshin Medipia Total Medical Check-up Center has been specializing in medical examination for the past 20 years, and have served over 2 million people. In addition, the center has been taken care of more than 20,000 foreign workers living in Korea every year from 2000 through 2008, totaling near 200,000 visitors. Their vision is to provide high-quality examination services to protect the health of people living overseas, as well as Korea residents. Hanshin Medipia is equipped with quality equipment, which includes devices for early cancer diagnosis PET-CT, MRI, CT and an image diagnosis system, as well as other hightech medical devices, to protect the health of the patients. For more information visit: http://www.hsmedipia.com/
About Infinity Care
Infiniti Care Research Institute Co. has been established to develop and provide an unceasing health care algorithm, the Healthcare Life Cycle, which is supported by such applications as OK Check-up, OK Dr. and others, which address different participants of the healthcare ecosystem, and link them into the continuous seamless process for the patient. So far the organisation
managed to accumulate more than 3 million personal records and continue to expand. By analysing hundreds of thousands of individual medical records, Infinity Care strives to improve the healthcare industry.
For more information visit: http://www.infinitycare.co.kr
Longenesis is a partnership between Insilico Medicine, a leading artificial intelligence company that uses deep learning for drug discovery, and the Bitfury Group, the leading full-service blockchain technology company. Longenesis is the exclusive healthcare application provider for open-source framework Exonum™. Through providing clinical data exchange solutions to key players in human health data industry and their vendors, Longenesis aims to re-define the process of patient consent recording and clinical data sales by providing a toolkit for transparent data requests by pharma, compliant paperless consent management and ability to reach out to every individual patient. For more information visit: www.longenesis.com.
About the Bitfury Group
The Bitfury Group is the world’s leading full-service blockchain technology company. Bitfury™ is building solutions for the future, with the most significant technologies of the millennium. Our mission is to make the world more transparent and trusted by innovating at every level of technology — hardware, security, and software — to put trust back into the equation. Founded in 2011, Bitfury is the leading security and infrastructure provider for the Bitcoin Blockchain. In addition to securing the Bitcoin Blockchain, Bitfury also designs and produces innovative hardware that keeps cryptocurrencies and blockchains secure, including custom semiconductor chips and mobile datacenters. Bitfury is also a software provider for the some of the world’s most cutting-edge applications through its Exonum™ private blockchain framework, its Crystal™ Blockchain advanced analytics platform, and its specialized engineering team for the open-source Lightning Network, Lightning Peach. To learn more, visit www.bitfury.com.